Pediatrix Medical Group Analyst Price Targets

Wall Street analyst price targets and consensus rating for Pediatrix Medical Group (MD).

Price Target Range — 13 Quarters

Analyst Consensus — 7 Analysts

1Buy

6Hold

Consensus RatingHold# Analysts7Avg. Consensus PT$20Upside to Avg. PT-33.4%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 30, 2026	Truist Securities	David Macdonald	PT Raise	Hold	$28→$31
Aug 19, 2026	Jefferies	Jack Slevin	Downgrade	Buy→Hold	$27→$28
Aug 6, 2026	UBS	A.J. Rice	PT Raise	Neutral	$25→$28
Jul 14, 2026	Truist Securities	David Macdonald	PT Raise	Hold	$23→$28
May 12, 2026	UBS	A.J. Rice	PT Raise	Neutral	$22→$25
Apr 13, 2026	Truist Securities	David Macdonald	PT Raise	Hold	$21→$23
Feb 24, 2026	UBS	A.J. Rice	PT Cut	Neutral	$23→$22
Feb 20, 2026	Truist Securities	David Macdonald	PT Cut	Hold	$24→$21
Nov 10, 2025	Truist Securities	David Macdonald	PT Raise	Hold	$17→$24
Nov 5, 2025	UBS	A.J. Rice	PT Raise	Neutral	$17→$23
Sep 5, 2025	Leerink Partners	Whit Mayo	PT Raise	Market Perform	$15→$17
Aug 14, 2025	UBS	A.J. Rice	PT Raise	Neutral	$16→$17
May 12, 2025	UBS	A.J. Rice	PT Cut	Neutral	$19→$16
May 8, 2025	Macquarie	Tao Qiu	PT Raise	Outperform	$19→$20
Apr 11, 2025	Truist Securities	David Macdonald	PT Cut	Hold	$18→$16
Feb 21, 2025	UBS	A.J. Rice	PT Raise	Neutral	$17→$19
Feb 21, 2025	Truist Securities	David Macdonald	PT Raise	Hold	$15→$18
Jan 6, 2025	Truist Securities	David Macdonald	PT Cut	Hold	$16→$15
Dec 16, 2024	Macquarie	Tao Qiu	Initiate	Outperform	$18
Nov 19, 2024	Mizuho	Ann Hynes	PT Raise	Neutral	$13→$15

Analyst Ratings News

PRO
Truist Securities Maintains Hold on Pediatrix Medical Group, Raises Price Target to $31

Truist Securities analyst David Macdonald maintains Pediatrix Medical Group (NYSE:MD) with a Hold and raises the price target from $28 to $31.

Benzinga Newsdesk

This Baidu Analyst Turns Bearish; Here Are Top 5 Downgrades For Wednesday

Wall Street analysts change outlook on top stocks, including BIDU and BMO. See their ratings and price targets on Benzinga's analyst page.

Avi Kapoor

PRO
Jefferies Downgrades Pediatrix Medical Group to Hold, Raises Price Target to $28

Jefferies analyst Jack Slevin downgrades Pediatrix Medical Group (NYSE:MD) from Buy to Hold and raises the price target from $27 to $28.

Benzinga Newsdesk

PRO
UBS Maintains Neutral on Pediatrix Medical Group, Raises Price Target to $28

UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and raises the price target from $25 to $28.

Benzinga Newsdesk

PRO
Truist Securities Maintains Hold on Pediatrix Medical Group, Raises Price Target to $28

Truist Securities analyst David Macdonald maintains Pediatrix Medical Group (NYSE:MD) with a Hold and raises the price target from $23 to $28.

Benzinga Newsdesk

PRO
UBS Maintains Neutral on Pediatrix Medical Group, Raises Price Target to $25

UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and raises the price target from $22 to $25.

Benzinga Newsdesk

Pediatrix Medical Group Inc

Pediatrix Medical Group Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Truist Securities Maintains Hold on Pediatrix Medical Group, Raises Price Target to $31

This Baidu Analyst Turns Bearish; Here Are Top 5 Downgrades For Wednesday

PRO
Jefferies Downgrades Pediatrix Medical Group to Hold, Raises Price Target to $28

PRO
UBS Maintains Neutral on Pediatrix Medical Group, Raises Price Target to $28

PRO
Truist Securities Maintains Hold on Pediatrix Medical Group, Raises Price Target to $28

PRO
UBS Maintains Neutral on Pediatrix Medical Group, Raises Price Target to $25

People Also Watch

People Also Watch

Pediatrix Medical Group Inc

Pediatrix Medical Group Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROTruist Securities Maintains Hold on Pediatrix Medical Group, Raises Price Target to $31

This Baidu Analyst Turns Bearish; Here Are Top 5 Downgrades For Wednesday

PROJefferies Downgrades Pediatrix Medical Group to Hold, Raises Price Target to $28

PROUBS Maintains Neutral on Pediatrix Medical Group, Raises Price Target to $28

PROTruist Securities Maintains Hold on Pediatrix Medical Group, Raises Price Target to $28

PROUBS Maintains Neutral on Pediatrix Medical Group, Raises Price Target to $25

People Also Watch

People Also Watch

PRO
Truist Securities Maintains Hold on Pediatrix Medical Group, Raises Price Target to $31

PRO
Jefferies Downgrades Pediatrix Medical Group to Hold, Raises Price Target to $28

PRO
UBS Maintains Neutral on Pediatrix Medical Group, Raises Price Target to $28

PRO
Truist Securities Maintains Hold on Pediatrix Medical Group, Raises Price Target to $28

PRO
UBS Maintains Neutral on Pediatrix Medical Group, Raises Price Target to $25